Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Spinal Disorders & Techniques|February 15, 2012
Medium-term clinical results of microsurgical lumbar flavectomy that preserves facet joints in cases of lumbar degenerative spondylolisthesis: comparison of bilateral laminotomy with bilateral decompression by a unilateral approachKazuyoshi Nakanishi, Nobuhiro Tanaka, Yoshinori Fujimoto, et al.
Chemical Research in Toxicology|August 29, 2019
Small-Scale Panel Comprising Diverse Gene Family Targets To Evaluate Compound PromiscuityTomoya Sameshima, Tomoya Yukawa, Yoshihiko Hirozane, et al.
Spine|February 25, 2016
Targeted Therapy for Low Back Pain in Elderly Degenerative Lumbar Scoliosis: A Cohort StudyKiyotaka Yamada, Toshio Nakamae, Takuro Shimbo, et al.
Spine|December 8, 2015
Bone Marrow Edema and Low Back Pain in Elderly Degenerative Lumbar Scoliosis: A Cross-Sectional StudyToshio Nakamae, Kiyotaka Yamada, Takuro Shimbo, et al.
Bioorganic & Medicinal Chemistry|October 8, 2011
Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancerTomohiro Kaku, Takenori Hitaka, Akio Ojida, et al.
Bioorganic & Medicinal Chemistry|February 9, 2017
Discovery of 4-chloro-2-(2,4-dichloro-6-methylphenoxy)-1-methyl-7-(pentan-3-yl)-1H-benzimidazole, a novel CRF1 receptor antagonistMichiyo Mochizuki, Takuto Kojima, Katsumi Kobayashi, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 18, 2021
Long-term outcome of targeted therapy for low back pain in elderly degenerative lumbar scoliosisKiyotaka Yamada, Toshio Nakamae, Kazuyoshi Nakanishi, et al.
Bioorganic & Medicinal Chemistry|June 9, 2015
Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitorIkuo Fujimori, Tomoya Yukawa, Taku Kamei, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 17, 2026
Preclinical characterization of pharmacokinetics, enzyme occupancy, and pharmacodynamics of soticlestat (TAK-935), a novel cholesterol 24-hydroxylase inhibitorMaki Miyamoto, Toshiya Nishi, Tatsuki Koike, et al.
Pageof 2